GFI1 and lung carcinoma: In addition, immunostaining of GFI1 in tissue sections of 18 primary human NSCLCs and their matched lymphatic metastases showed that among the 10 patients whose primary tumors expressed GFI1, 8 had more GFI1-expressing lung cancer cells in lymphatic metastases than their corresponding primary tumors (Figure 4E).